Progyny, Inc. (NASDAQ:PGNY) Stake Reduced by California State Teachers Retirement System

California State Teachers Retirement System cut its holdings in Progyny, Inc. (NASDAQ:PGNY) by 11.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 71,947 shares of the company’s stock after selling 9,031 shares during the quarter. California State Teachers Retirement System owned about 0.08% of Progyny worth $1,241,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Signaturefd LLC raised its position in Progyny by 1,355.0% in the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock worth $25,000 after acquiring an additional 1,355 shares in the last quarter. Natixis bought a new stake in Progyny in the fourth quarter worth about $69,000. SBI Securities Co. Ltd. bought a new stake in Progyny in the fourth quarter worth about $74,000. KBC Group NV raised its position in Progyny by 84.6% in the fourth quarter. KBC Group NV now owns 4,669 shares of the company’s stock worth $81,000 after acquiring an additional 2,140 shares in the last quarter. Finally, Amundi bought a new stake in Progyny in the fourth quarter worth about $102,000. 94.93% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Bank of America boosted their price target on shares of Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. Canaccord Genuity Group dropped their price target on Progyny from $23.00 to $21.00 and set a “hold” rating on the stock in a research note on Monday, May 12th. Finally, BTIG Research raised Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price target on the stock in a research note on Monday, March 31st. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Progyny presently has a consensus rating of “Hold” and a consensus price target of $23.45.

Progyny Price Performance

NASDAQ:PGNY opened at $21.97 on Tuesday. Progyny, Inc. has a fifty-two week low of $13.39 and a fifty-two week high of $30.42. The stock’s 50-day moving average is $22.00 and its two-hundred day moving average is $20.48. The stock has a market cap of $1.88 billion, a PE ratio of 37.88, a price-to-earnings-growth ratio of 2.39 and a beta of 1.32.

Progyny (NASDAQ:PGNY) last released its earnings results on Thursday, May 8th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The business had revenue of $324.04 million for the quarter, compared to analysts’ expectations of $307.86 million. During the same period last year, the firm earned $0.17 EPS. The company’s revenue was up 16.5% compared to the same quarter last year. On average, equities research analysts anticipate that Progyny, Inc. will post 0.6 earnings per share for the current year.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.